Cargando…

Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice

BACKGROUND: Premature ovarian insufficiency (POI) is an ovarian dysfunction that seriously affects a woman’s physiological health and reproduction. Mesenchymal stem cell (MSC) transplantation offers a promising treatment option for ovarian restoration in rodent POI models. However, the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Ma, Jiao, Yi, Peiye, Wu, Jun, Zhao, Feiyan, Tu, Wan, Liu, Wenjing, Li, Tianda, Deng, Yan, Hao, Jie, Wang, Hongmei, Yan, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641864/
https://www.ncbi.nlm.nih.gov/pubmed/33148334
http://dx.doi.org/10.1186/s13287-020-01972-5
_version_ 1783606013211967488
author Zhao, Yan
Ma, Jiao
Yi, Peiye
Wu, Jun
Zhao, Feiyan
Tu, Wan
Liu, Wenjing
Li, Tianda
Deng, Yan
Hao, Jie
Wang, Hongmei
Yan, Long
author_facet Zhao, Yan
Ma, Jiao
Yi, Peiye
Wu, Jun
Zhao, Feiyan
Tu, Wan
Liu, Wenjing
Li, Tianda
Deng, Yan
Hao, Jie
Wang, Hongmei
Yan, Long
author_sort Zhao, Yan
collection PubMed
description BACKGROUND: Premature ovarian insufficiency (POI) is an ovarian dysfunction that seriously affects a woman’s physiological health and reproduction. Mesenchymal stem cell (MSC) transplantation offers a promising treatment option for ovarian restoration in rodent POI models. However, the efficacy and mechanism of it remain unclear. METHODS: POI mice model was generated by cyclophosphamide and busulfan, followed with the treatment of tail-vein injection of the human umbilical cord mesenchymal stem cells (hUCMSCs). Maternal physiological changes and offspring behavior were detected. To reveal the pathogenesis and therapeutic mechanisms of POI, we first compared the metabolite profiles of healthy and POI ovarian tissues using untargeted metabolomics analyses. After stem cell therapy, we then collected the ovaries from control, POI, and hUCMSC-treated POI groups for lipid metabolomics and pseudotargeted metabolomics analysis. RESULTS: Our results revealed remarkable changes of multiple metabolites, especially lipids, in ovarian tissues after POI generation. Following the transplantation of clinical-grade hUCMSCs, POI mice exhibited significant improvements in body weight, sex hormone levels, estrous cycles, and reproductive capacity. Lipid metabolomics and pseudotargeted metabolomics analyses for the ovaries showed that the metabolite levels in the POI group, mainly lipids, glycerophospholipids, steroids, and amino acids changed significantly compared with the controls’, and most of them returned to near-healthy levels after receiving hUCMSC treatment. Meanwhile, we also observed an increase of monosaccharide levels in the ovaries from POI mice and a decrease after stem cell treatment. CONCLUSIONS: hUCMSCs restore ovarian function through activating the PI3K pathway by promoting the level of free amino acids, consequently improving lipid metabolism and reducing the concentration of monosaccharides. These findings provide potential targets for the clinical diagnosis and treatment of POI.
format Online
Article
Text
id pubmed-7641864
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76418642020-11-05 Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice Zhao, Yan Ma, Jiao Yi, Peiye Wu, Jun Zhao, Feiyan Tu, Wan Liu, Wenjing Li, Tianda Deng, Yan Hao, Jie Wang, Hongmei Yan, Long Stem Cell Res Ther Research BACKGROUND: Premature ovarian insufficiency (POI) is an ovarian dysfunction that seriously affects a woman’s physiological health and reproduction. Mesenchymal stem cell (MSC) transplantation offers a promising treatment option for ovarian restoration in rodent POI models. However, the efficacy and mechanism of it remain unclear. METHODS: POI mice model was generated by cyclophosphamide and busulfan, followed with the treatment of tail-vein injection of the human umbilical cord mesenchymal stem cells (hUCMSCs). Maternal physiological changes and offspring behavior were detected. To reveal the pathogenesis and therapeutic mechanisms of POI, we first compared the metabolite profiles of healthy and POI ovarian tissues using untargeted metabolomics analyses. After stem cell therapy, we then collected the ovaries from control, POI, and hUCMSC-treated POI groups for lipid metabolomics and pseudotargeted metabolomics analysis. RESULTS: Our results revealed remarkable changes of multiple metabolites, especially lipids, in ovarian tissues after POI generation. Following the transplantation of clinical-grade hUCMSCs, POI mice exhibited significant improvements in body weight, sex hormone levels, estrous cycles, and reproductive capacity. Lipid metabolomics and pseudotargeted metabolomics analyses for the ovaries showed that the metabolite levels in the POI group, mainly lipids, glycerophospholipids, steroids, and amino acids changed significantly compared with the controls’, and most of them returned to near-healthy levels after receiving hUCMSC treatment. Meanwhile, we also observed an increase of monosaccharide levels in the ovaries from POI mice and a decrease after stem cell treatment. CONCLUSIONS: hUCMSCs restore ovarian function through activating the PI3K pathway by promoting the level of free amino acids, consequently improving lipid metabolism and reducing the concentration of monosaccharides. These findings provide potential targets for the clinical diagnosis and treatment of POI. BioMed Central 2020-11-04 /pmc/articles/PMC7641864/ /pubmed/33148334 http://dx.doi.org/10.1186/s13287-020-01972-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Yan
Ma, Jiao
Yi, Peiye
Wu, Jun
Zhao, Feiyan
Tu, Wan
Liu, Wenjing
Li, Tianda
Deng, Yan
Hao, Jie
Wang, Hongmei
Yan, Long
Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
title Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
title_full Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
title_fullStr Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
title_full_unstemmed Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
title_short Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
title_sort human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641864/
https://www.ncbi.nlm.nih.gov/pubmed/33148334
http://dx.doi.org/10.1186/s13287-020-01972-5
work_keys_str_mv AT zhaoyan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT majiao humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT yipeiye humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT wujun humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT zhaofeiyan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT tuwan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT liuwenjing humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT litianda humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT dengyan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT haojie humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT wanghongmei humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice
AT yanlong humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice